ECOG-ACRIN logoECOG-ACRIN logoECOG-ACRIN logoECOG-ACRIN logo
  • Home
  • Archives
  • Contact
✕
  • Filter by
  • Categories
  • Tags
  • Authors
  • Show all
  • All
  • Advocacy
  • Anal cancer
  • Artificial intelligence (AI)
  • Bladder cancer
  • Brain cancer
  • Breast cancer
  • Colorectal cancer
  • ComboMATCH
  • Esophagus cancer
  • Gallbladder cancer
  • Head and neck cancer
  • Health equity
  • Immunotherapy
  • In memory
  • Kidney cancer
  • Leukemia
  • Liver cancer
  • Lung cancer
  • Lymphoma
  • Mammography
  • Melanoma
  • Myelodysplastic syndrome
  • Myeloma
  • NCI-MATCH
  • Older adults
  • Pancreatic cancer
  • Pancreatic cysts
  • Patient education
  • Patient navigation
  • Patient-reported outcomes
  • Penis cancer
  • Personalized treatment
  • Policy
  • Precision medicine
  • Prevention
  • Prostate cancer
  • Real-world data/evidence
  • Research results
  • Sarcoma
  • Screening for cancer
  • Side effects
  • Survivorship
  • Targeted therapy
  • Upper tract urothelial cancer
  • Upper urinary tract cancer
  • Young adults
November 3, 2025
Patient and doctor talking over clipboard
November 3, 2025
Categories
  • Ongoing Trials

Ongoing Trials: A closer look at ECOG-ACRIN’s clinical trials for patients with pancreatic conditions

For Pancreatic Cancer Awareness Month, we highlight two actively recruiting clinical trials for patients with pancreatic conditions
Do you like it?
0 Read more
July 24, 2025
July 24, 2025
Categories
  • Ongoing Trials

Ongoing Trials: A closer look at ECOG-ACRIN’s clinical trials for patients with sarcoma 

For Sarcoma Awareness Month, we highlight two actively recruiting clinical trials for patients with this rare cancer, which has had few treatment advances
Do you like it?
0 Read more
May 19, 2025
May 19, 2025
Categories
  • Ongoing Trials

Ongoing Trials: A closer look at ECOG-ACRIN’s studies for patients with head and neck cancer

These four actively recruiting clinical trials are exploring possible new treatment approaches
Do you like it?
0 Read more
January 16, 2025
Women laughing together
January 16, 2025
Categories
  • Ongoing Trials

Ongoing Trial: The TMIST breast cancer screening trial has achieved its enrollment goal, paving the way for a precision approach to screening

More than 108,000 women across the world joined the study of 2-D versus 3-D mammography
Do you like it?
0 Read more
Prev page
1234567
Next page

Office of Communications
1818 Market Street, Suite 3000
Philadelphia, PA 19103
Phone: 215.789.3631
www.ecog-acrin.org

Contact us with any questions

© 2019-2026 ECOG-ACRIN Cancer Research Group. All Rights Reserved. Designed by Create & Associates, Inc